Just Evotec Biologics
Invenra accelerates your next-generation antibody discovery by specializing in rapid bispecific, trispecific and multispecific antibody development using our clinically validated B-Body™ and
T-Body™ platforms. The B-Body™ and T-Body™ systems address common challenges in multispecific development—including expression yields, stability, and purification complexity—while maintaining the flexibility to accommodate diverse target combinations and therapeutic modalities. Our Fab-based technologies integrate engineered specificity with manufacturing compatibility, enabling streamlined workflows that deliver optimized bispecific antibodies in four months from partner antigens or two months from existing monoclonal antibody panels.
